Parallel Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9K Sell
720
-614
-46% -$14.5K ﹤0.01% 2594
2025
Q4
$43.3K Buy
1,334
+50
+4% +$2.14K ﹤0.01% 1916
2025
Q3
$72.8K Buy
1,284
+129
+11% +$6.61K ﹤0.01% 1587
2025
Q2
$57.6K Buy
1,155
+735
+175% +$33.2K ﹤0.01% 1640
2025
Q1
$12.4K Buy
420
+329
+362% +$12.2K ﹤0.01% 2349
2024
Q4
$2.2K Buy
91
+24
+36% +$595 ﹤0.01% 2938
2024
Q3
$1.23K Sell
67
-10
-13% -$179 ﹤0.01% 2992
2024
Q2
$1.55K Buy
+77
New +$1.28K ﹤0.01% 2862
2021
Q1
Sell
-50
Closed -$1K 2837
2020
Q4
$1K Buy
+50
New +$555 ﹤0.01% 2430

Other funds holding HIMS

Parallel Advisors's HIMS Position: Q1 2026 in Review

Parallel Advisors reduced its Hims & Hers Health (HIMS) stake by 46% in Q1 2026, selling an estimated $14.5K and leaving 720 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

Parallel Advisors first reported a position in HIMS in Q4 2020 and has held it in 9 quarters since. The position peaked at $72.8K in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Parallel Advisors held 720 shares of Hims & Hers Health worth $14.9K as of Q1 2026.
  • Parallel Advisors sold 614 Hims & Hers Health shares in Q1 2026, an estimated $14.5K.
  • Hims & Hers Health made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2594 holding.
  • Parallel Advisors first reported a position in Hims & Hers Health in Q4 2020 and has held it in 9 quarters since.
  • Parallel Advisors's Hims & Hers Health position peaked at $72.8K in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.